Clinical evaluation of biologically targeted drugs: Obstacles and opportunities

Anthony L. Boral, Scott Dessain, Bruce A. Chabner

Open source

DOI: 10.1007/s002800051075
Published: 1998-08
Container: Cancer Chemotherapy and Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s002800051075,
  title = {Clinical evaluation of biologically targeted drugs: Obstacles and opportunities},
  author = {Anthony L. Boral and Scott Dessain and Bruce A. Chabner},
  year = {1998},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s002800051075},
  url = {https://doi.org/10.1007/s002800051075}
}

RIS

TY  - JOUR
TI  - Clinical evaluation of biologically targeted drugs: Obstacles and opportunities
AU  - Anthony L. Boral
AU  - Scott Dessain
AU  - Bruce A. Chabner
PY  - 1998
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s002800051075
UR  - https://doi.org/10.1007/s002800051075
ER  -

APA

Boral, A. L., Dessain, S., & Chabner, B. A. (1998). Clinical evaluation of biologically targeted drugs: Obstacles and opportunities. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s002800051075

Source records

crossref · retrieved 2026-09-25T02:06:59.820Z